Black Diamond Therapeutics, Inc. (BDTX) Financials

BDTX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 125.0 million 28.9 million
March 31, 2026 132.9 million 28.6 million
Dec. 31, 2025 143.0 million 30.8 million
Sept. 30, 2025 157.7 million 31.6 million

BDTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -7.1 million 1.5 million
March 31, 2026 -10.2 million 1.4 million
Dec. 31, 2025 -6.8 million 1.4 million
Sept. 30, 2025 -7.9 million 1.7 million

BDTX Net Income

No data available :(

BDTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 110.5 million - 17.0 million
March 31, 2026 118.3 million - 14.1 million
Dec. 31, 2025 128.7 million - 18.8 million
Sept. 30, 2025 135.5 million - 19.7 million

BDTX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 57.4 million
March 31, 2026 57.2 million
Dec. 31, 2025 57.1 million
Sept. 30, 2025 56.9 million

BDTX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 7.4 million 4.7 million -
March 31, 2026 - 7.0 million 4.3 million -
Dec. 31, 2025 - 6.3 million 4.0 million -
Sept. 30, 2025 - 7.4 million 3.5 million -

BDTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 27000
Dec. 31, 2025 - 66000
Sept. 30, 2025 - -

BDTX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

BDTX

Price: $2.02

52 week price:
1.60
4.94

Earnings Per Share: -0.75 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 81500

Market Capitalization: 120.3 million

Links: